Stem Cell Research

Creative Biolabs Enhances Cell Therapy Research with Advanced iPSC and Macrophage Solutions

Creative Biolabs Enhances Cell Therapy Research with Advanced iPSC and Macrophage Solutions

Creative Biolabs introduces innovative tools and services for iPSC neural differentiation and macrophage isolation, significantly advancing cell therapy research and disease modeling.

July 24, 2025
Stem Cell and Gene Therapy Innovations Poised to Transform Medicine

Stem Cell and Gene Therapy Innovations Poised to Transform Medicine

The stem cell and gene therapy sectors are experiencing rapid growth, with innovations from companies like Adia Nutrition Inc., Mesoblast, Lineage Cell Therapeutics, and CRISPR Therapeutics leading the charge towards transformative treatments for serious diseases.

June 30, 2025
Study Reveals Viability of Ambient Temperature Transport for Human Oocytes, Opening New Research Avenues

Study Reveals Viability of Ambient Temperature Transport for Human Oocytes, Opening New Research Avenues

A groundbreaking study demonstrates that human oocytes can be transported at ambient temperature without losing viability, offering new opportunities for research in reproductive medicine and stem cell therapy.

June 23, 2025
Breakthrough Stem Cell Dog Chews Show Promising Results in Veterinary Trials

Breakthrough Stem Cell Dog Chews Show Promising Results in Veterinary Trials

Bioadaptives Inc's PawPa division has developed Regen Dog Chews that demonstrate significant potential for improving canine health through natural stem cell stimulation, with clinical trials showing a dramatic increase in circulating stem cells.

May 28, 2025
Creative Biolabs Expands Induced Pluripotent Stem Cell Research Services

Creative Biolabs Expands Induced Pluripotent Stem Cell Research Services

Creative Biolabs introduces comprehensive induced pluripotent stem cell (iPSC) services, offering researchers advanced tools to accelerate stem cell therapy research and development across multiple disease domains.

April 18, 2025